Professor Wm. Ted Brown is the retired Director of the New York State Institute for Basic Research (IBR) in Developmental Disabilities, Staten Island, NY.

Born in Montana, USA, Prof Brown received his PhD from Johns Hopkins and his MD from Harvard.

Upon retiring, Prof Brown moved to Sydney for 6 years and had an appointment as Visiting Professor at the University of Sydney.

Prof Brown is a fellow of the American Board of Internal Medicine and the American College of Medical Genetics. Much of his 35 year research career has focused on the Fragile X syndrome and on autism. Prof Brown was the first to describe a relationship between autism and the Fragile X syndrome. His team was the first to demonstrate the feasibility of prenatal diagnosis for Fragile X, and subsequently have provided prenatal diagnosis for more than 1,400 known carriers.  His laboratory has developed a sensitive antibody test to quantify the fragile X protein levels in blood spots. His clinic was a participant in the Fragile X drug trials sponsored by Seaside, Novartis and Roche.  He was the principal investigator on a CDC sponsored study of the natural history of Fragile X that included 26 clinics in the US.
Prof Brown is the immediate Past President of FXAA. He was re-appointed to the Board for a fourth term at the Annual General Meeting on 1 December 2024.